STOCK TITAN

LifeStance Health Group Inc - LFST STOCK NEWS

Welcome to our dedicated news page for LifeStance Health Group (Ticker: LFST), a resource for investors and traders seeking the latest updates and insights on LifeStance Health Group.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect LifeStance Health Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of LifeStance Health Group's position in the market.

Rhea-AI Summary
LifeStance Health Group, Inc. (NASDAQ: LFST) will host its first quarter 2024 earnings conference call on May 9, 2024, to discuss financial results. The call will take place at 8:30 a.m. Eastern Time. Participants can join via phone or webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
Rhea-AI Summary
LifeStance Health appoints Dr. Teresa DeLuca, an experienced healthcare executive and psychiatrist, to its board of directors. Dr. DeLuca brings over 20 years of leadership experience from companies like Magellan Health and Humana, enhancing LifeStance's clinical management and healthcare operations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.96%
Tags
management
-
Rhea-AI Summary
LifeStance Health Group, Inc. (LFST) reports strong financial results for Q4 and full year 2023, with revenue up 22% and 23% respectively. The company experienced an 18% increase in clinician base, with positive outlook for 2024. Despite a net loss due to stock-based compensation and lawsuit settlement, Adjusted EBITDA showed positive growth. Center Margin and visit volumes also saw significant improvements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
30%
Tags
Rhea-AI Summary
LifeStance Health Group, Inc. (NASDAQ: LFST) will release its fourth quarter and full year 2023 earnings on February 28, 2024. The company will host a live earnings conference call to discuss the results. Participants can join the call via phone or webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.65%
Tags
conferences earnings
-
Rhea-AI Summary
LifeStance Health appoints Dr. Ujjwal Ramtekkar as Chief Medical Officer, a double board-certified pediatric and adult psychiatrist with a track record of driving exceptional patient and clinical outcomes. He will lead clinical services to deliver high-quality mental healthcare and will replace Dr. Anisha Patel-Dunn, who is stepping down to spend more time with her family.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.89%
Tags
management
-
Rhea-AI Summary
LifeStance Health Group, Inc. (Nasdaq: LFST) announced Q3 2023 financial results, including a 21% increase in total revenue to $262.9 million, a net loss of $61.6 million, and raising guidance for full year 2023 revenue to $1.03 to $1.04 billion. The company's CEO highlighted strong financial results and organic clinician growth, with a record quarter of recruiting nearly 300 clinicians.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.13%
Tags
Rhea-AI Summary
LifeStance Health Group, Inc. to release third quarter earnings on November 8, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.9%
Tags
conferences earnings
-
Rhea-AI Summary
LifeStance Health Group, Inc. (NASDAQ: LFST) to present at 7th Annual Bernstein Healthcare Services Disruptors Conference on October 4, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.02%
Tags
conferences
-
Rhea-AI Summary
LifeStance Health Group, Inc. to present at Morgan Stanley Global Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.66%
Tags
conferences
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.14%
Tags
LifeStance Health Group Inc

Nasdaq:LFST

LFST Rankings

LFST Stock Data

2.30B
86.36M
10.7%
86.83%
5.31%
Dental Laboratories
Manufacturing
Link
US
Scottsdale

About LFST

lifestance health is a behavioral health care company focused on providing evidenced-based, medically driven treatment services for children, adolescents and adults suffering from a variety of mental health issues in care settings that include acute inpatient, partial hospitalization, intensive outpatient, outpatient, community-based and in-home. at lifestance, patient care is paramount – the driving force in everything we do. we are committed to state-of-the-art clinical excellence, to partnership and collaboration with other treating health care providers to ensure continuity of care, to utilization of data to individually tailor our services for continual improvement in outcomes, and to empowering our patients to make informed choices and help them achieve their goals. all in a compassionate and safe environment that provides education, support and best practices in integrated care.